Standard

Гемистоцитарные астроцитомы. / Matsko, D. E.; Zrelov, A. A.; Ulitin, A. Yu; Matsko, M. V.; Skliar, S. S.; Baksheeva, A. O.; Imyanitov, E. N.

In: АРХИВ ПАТОЛОГИИ, Vol. 80, No. 4, 2018, p. 27-38.

Research output: Contribution to journalReview articlepeer-review

Harvard

Matsko, DE, Zrelov, AA, Ulitin, AY, Matsko, MV, Skliar, SS, Baksheeva, AO & Imyanitov, EN 2018, 'Гемистоцитарные астроцитомы', АРХИВ ПАТОЛОГИИ, vol. 80, no. 4, pp. 27-38. https://doi.org/10.17116/patol201880427, https://doi.org/10.17116/patol201880427

APA

Matsko, D. E., Zrelov, A. A., Ulitin, A. Y., Matsko, M. V., Skliar, S. S., Baksheeva, A. O., & Imyanitov, E. N. (2018). Гемистоцитарные астроцитомы. АРХИВ ПАТОЛОГИИ, 80(4), 27-38. https://doi.org/10.17116/patol201880427, https://doi.org/10.17116/patol201880427

Vancouver

Matsko DE, Zrelov AA, Ulitin AY, Matsko MV, Skliar SS, Baksheeva AO et al. Гемистоцитарные астроцитомы. АРХИВ ПАТОЛОГИИ. 2018;80(4):27-38. https://doi.org/10.17116/patol201880427, https://doi.org/10.17116/patol201880427

Author

Matsko, D. E. ; Zrelov, A. A. ; Ulitin, A. Yu ; Matsko, M. V. ; Skliar, S. S. ; Baksheeva, A. O. ; Imyanitov, E. N. / Гемистоцитарные астроцитомы. In: АРХИВ ПАТОЛОГИИ. 2018 ; Vol. 80, No. 4. pp. 27-38.

BibTeX

@article{b13ab9172eac4be785ca88d71196bc0b,
title = "Гемистоцитарные астроцитомы",
abstract = "Gemistocytic astrocytomas (GA) are a variant of diffuse astrocytomas GII (WHO, 2016). Like all diffuse astrocytomas, GA recur with time, which is often accompanied by malignant degeneretion into the anaplastic astrocytoma GIII or to the secondary glioblastoma GIV. However, the progression-free survival and overall survival in patients with GA is less than in patients with diffuse astrocytomas. Given that this group of patients, according to the WHO classification (2016), is classified as GII, patients with GA usually do not receive comprehensive treatment. We have conducted a thorough analysis of research on this problem for the period from 1956 to 2017. Differences in the histological pattern, immunohistochemical and molecular-genetic profiles, survival of patients with GA and diffuse astrocytomas GII are shown there. A clinical case of a patient with transformation of a diffuse astrocytoma in GA (GIII) and then into a secondary glioblastoma is presented.",
keywords = "Diffuse astrocytoma, Gemistocytic astrocytoma, Molecular-genetic features",
author = "Matsko, {D. E.} and Zrelov, {A. A.} and Ulitin, {A. Yu} and Matsko, {M. V.} and Skliar, {S. S.} and Baksheeva, {A. O.} and Imyanitov, {E. N.}",
note = "Publisher Copyright: {\textcopyright} 2018 Media Sphera Publishing Group. All rights reserved.",
year = "2018",
doi = "10.17116/patol201880427",
language = "русский",
volume = "80",
pages = "27--38",
journal = "АРХИВ ПАТОЛОГИИ",
issn = "0004-1955",
publisher = "Медиа Сфера",
number = "4",

}

RIS

TY - JOUR

T1 - Гемистоцитарные астроцитомы

AU - Matsko, D. E.

AU - Zrelov, A. A.

AU - Ulitin, A. Yu

AU - Matsko, M. V.

AU - Skliar, S. S.

AU - Baksheeva, A. O.

AU - Imyanitov, E. N.

N1 - Publisher Copyright: © 2018 Media Sphera Publishing Group. All rights reserved.

PY - 2018

Y1 - 2018

N2 - Gemistocytic astrocytomas (GA) are a variant of diffuse astrocytomas GII (WHO, 2016). Like all diffuse astrocytomas, GA recur with time, which is often accompanied by malignant degeneretion into the anaplastic astrocytoma GIII or to the secondary glioblastoma GIV. However, the progression-free survival and overall survival in patients with GA is less than in patients with diffuse astrocytomas. Given that this group of patients, according to the WHO classification (2016), is classified as GII, patients with GA usually do not receive comprehensive treatment. We have conducted a thorough analysis of research on this problem for the period from 1956 to 2017. Differences in the histological pattern, immunohistochemical and molecular-genetic profiles, survival of patients with GA and diffuse astrocytomas GII are shown there. A clinical case of a patient with transformation of a diffuse astrocytoma in GA (GIII) and then into a secondary glioblastoma is presented.

AB - Gemistocytic astrocytomas (GA) are a variant of diffuse astrocytomas GII (WHO, 2016). Like all diffuse astrocytomas, GA recur with time, which is often accompanied by malignant degeneretion into the anaplastic astrocytoma GIII or to the secondary glioblastoma GIV. However, the progression-free survival and overall survival in patients with GA is less than in patients with diffuse astrocytomas. Given that this group of patients, according to the WHO classification (2016), is classified as GII, patients with GA usually do not receive comprehensive treatment. We have conducted a thorough analysis of research on this problem for the period from 1956 to 2017. Differences in the histological pattern, immunohistochemical and molecular-genetic profiles, survival of patients with GA and diffuse astrocytomas GII are shown there. A clinical case of a patient with transformation of a diffuse astrocytoma in GA (GIII) and then into a secondary glioblastoma is presented.

KW - Diffuse astrocytoma

KW - Gemistocytic astrocytoma

KW - Molecular-genetic features

UR - http://www.scopus.com/inward/record.url?scp=85050795930&partnerID=8YFLogxK

U2 - 10.17116/patol201880427

DO - 10.17116/patol201880427

M3 - Обзорная статья

C2 - 30059069

AN - SCOPUS:85050795930

VL - 80

SP - 27

EP - 38

JO - АРХИВ ПАТОЛОГИИ

JF - АРХИВ ПАТОЛОГИИ

SN - 0004-1955

IS - 4

ER -

ID: 39064719